ONE NUCLEUS STRENGTHENS BOARD WITH APPOINTMENT OF NEW DIRECTOR

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
About Healx
Healx is an AI-powered tech bio company redesigning drug discovery. With over 10,000 rare diseases affecting 400 million people globally - and 90% lacking approved treatments - our mission is to pioneer a new generation of drug discovery to bring treatments to patients faster.
We combine data, artificial intelligence and deep pharmacology expertise to develop therapies more efficiently and cost-effectively than traditional approaches.
Open to all scientists researching new therapeutics in Cambridge and the local area.
The purpose of the CamNTF forum is to promote interactions between scientists from academia & industry in order to improve opportunities for biotechnology research and development. Meeting attendance is free but all attendees must register in advance.

The evening cocktail reception at Australia House in London will provides direct access to biotech stakeholders within the city’s thriving ecosystem. This networking event will highlight high-value collaboration opportunities by showcasing the Australia as a global leading destination for conducting efficient and cost-effective clinical trials. To further group these connections, the session will be complemented by supplemental site visits within the city biotech ecosystem.
Fast growing techbio: data, computational research, IP and how to leverage those for commercial success
Join us for a panel discussion and networking event at our new London office and hear from people with a passion for techbio.
We're bringing together key stakeholders from across the ecosystem, and they'll be sharing invaluable insights and experiences crucial for success.
Our discussion will encompass topics such as:
About us:
LifeArc is a not-for-profit life science organisation, leading the way for change in rare diseases in the UK and supporting promising initiatives in global health. We seek out research in areas of unmet need that has great potential, providing support to help it become breakthroughs that change lives.
About the role:
Supporting our network's growth remains at the heart of what we do. Explore our upcoming learning opportunities and discover how you can continue to develop your skills, connect with others, and stay ahead in the sector.
________________________________________________
One Nucleus Training
*Guest blog by Romy Frow at Travel Counsellors. If you would like to submit a guest blog please email [email protected].
Business travel has always had a lot of moving parts: flights, hotels, ground transport, budgets and policies. Today, it also means navigating constantly changing geopolitics, airline schedule changes and sudden disruptions, such as the recent events and airspace restrictions in the Middle East.
LONDON, UK and COPENHAGEN, Denmark – April 22, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for Oral Care AB and is pleased to announce the placement of Lucas Kromann as Chief Executive Officer (CEO) Denmark.
Healx is an AI-powered tech bio company redesigning drug discovery. With over 10,000 rare diseases affecting 400 million people globally - and 90% lacking approved treatments - our mission is to pioneer a new generation of drug discovery to bring treatments to patients faster.
We combine data, artificial intelligence and deep pharmacology expertise to develop therapies more efficiently and cost-effectively than traditional approaches.